You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

myeloma protein A48, mouse

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Atlanta (Tocilizumab, Venetoclax)

Recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Jan 24, 2023

Project in First-degree Relatives of Myeloma Patient - The

Recruiting
  • Multiple Myeloma
  • Monoclonal Gammopathy of Undetermined Significance
  • Sample of Blood
  • Shanghai, Shanghai, China
    Zhongshan Hospital，Fudan University
Jul 31, 2023

Positive Rate of M Protein Based onHighly Sensitive Serum M

Recruiting
  • Multiple Myeloma
  • M Protein
    • Guangzhou, Guangdong, China
      Zhujiang Hospital of Southern Medical University
    Oct 9, 2023

    Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma Trial in Cleveland (Multiple

    Not yet recruiting
    • Multiple Myeloma
    • +2 more
    • Multiple Myeloma M-Protein Analysis
    • Multiple Myeloma Knowledge Questionnaires
    • Cleveland, Ohio
      Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
    Apr 26, 2023

    Multiple Myeloma, Tumors, Tumor, Plasma Cell Trial (Belantamab Mafodotin-Blmf, Lenalidomide, Dexamethasone)

    Not yet recruiting
    • Multiple Myeloma
    • +7 more
    • Belantamab Mafodotin-Blmf
    • +3 more
    • (no location specified)
    Oct 11, 2022

    Multiple Myeloma Trial in Hackensack (Bortezomib)

    Terminated
    Has Results
    • Multiple Myeloma
    • Hackensack, New Jersey
      The Cancer Center at Hackensack University Medical Center
    Jun 24, 2022

    Multiple Myeloma, Multiple Myeloma in Relapse, Tumors Trial (Belantamab Mafodotin-Blmf, Daratumumab, Pomalidomide)

    Not yet recruiting
    • Multiple Myeloma
    • +8 more
    • Belantamab Mafodotin-Blmf
    • +3 more
    • (no location specified)
    Oct 13, 2022

    Multiple Myeloma Trial in Little Rock (Carfilzomib, Thalidomide, Dexamethasone)

    Active, not recruiting
    • Multiple Myeloma
    • Little Rock, Arkansas
      University of Arkansas for Medical Sciences
    Sep 1, 2022

    Multiple Myeloma, Tumors, Tumors, Plasma Cell Trial (Belantamab Mafodotin-Blmf, Daratumumab, Lenalidomide)

    Not yet recruiting
    • Multiple Myeloma
    • +7 more
    • Belantamab Mafodotin-Blmf
    • +3 more
    • (no location specified)
    Mar 4, 2022

    Multiple Myeloma, Tumor, Plasma Cell, Tumors by Histologic Type Trial in United States (CYNK-001)

    Active, not recruiting
    • Multiple Myeloma
    • +19 more
    • CYNK-001
    • Denver, Colorado
    • +8 more
    May 24, 2022

    Multiple Myeloma, Renal Impairment, Tumors, Plasma Cell Trial in Greece (Isatuximab, Bortezomib, Cyclophosphamide)

    Not yet recruiting
    • Multiple Myeloma
    • +7 more
    • Athens, Greece
    • +5 more
    Mar 28, 2022

    Multiple Myeloma, Renal Impairment, Tumors, Plasma Cell Trial in Greece (Isatuximab, Pomalidomide, Dexamethasone)

    Not yet recruiting
    • Multiple Myeloma
    • +7 more
    • Athens, Greece
    • +5 more
    Mar 17, 2022

    CORONADO

    Recruiting
    • Multiple Myeloma
    • n/a - samples collected along routine care samples only
    • Sutton, United Kingdom
      The Royal Marsden NHS Foundation Trust
    Mar 9, 2021

    Monoclonal Gammopathies, Multiple Myeloma, M-protein Trial in Guangzhou (Observational studies, no intervention)

    Recruiting
    • Monoclonal Gammopathies
    • +2 more
    • Observational studies, no intervention
    • Guangzhou, Guangdong, China
      Zhujiang Hospital of Southern Medical University
    Jan 6, 2023

    Contraceptives, Oral, Sex Hormone Trial in Toronto (Protein tracer drink)

    Recruiting
    • Contraceptives, Oral
    • Sex Hormone
    • Protein tracer drink
    • Toronto, Ontario, Canada
      Goldring Centre for High Performance Sport at the University of
    Nov 8, 2023

    Multiple Myeloma Trial in Ann Arbor (Iodine I 131 Tositumomab)

    Active, not recruiting
    Has Results
    • Multiple Myeloma
    • Iodine I 131 Tositumomab
    • Ann Arbor, Michigan
      University of Michigan
    Mar 16, 2022

    Multiple Myeloma in Relapse Trial in Shenzhen (BCMA/GPRC5D double CAR-T)

    Recruiting
    • Multiple Myeloma in Relapse
    • BCMA/GPRC5D double CAR-T
    • Shenzhen, Guangdong, China
      Shenzhen Qianhai Shekou Free Trade Zone Hospital
    Sep 28, 2023

    Smoldering Multiple Myeloma Trial (Selinexor)

    Not yet recruiting
    • Smoldering Multiple Myeloma
    • (no location specified)
    Oct 27, 2022

    Multiple Myeloma Trial in Shanghai (Osalmid)

    Active, not recruiting
    • Multiple Myeloma
    • Shanghai, Shanghai, China
      Shanghai 10th People's Hospital
    May 17, 2021

    Multiple Myeloma Trial in Wuhan (Plasma-free procedure)

    Completed
    • Multiple Myeloma
    • Plasma-free procedure
    • Wuhan, Hubei, China
      Zhongnan Hospital of Wuhan University
    Feb 10, 2022

    Optical Genome Mapping in Characterization of Multiple Myeloma

    Not yet recruiting
    • Multiple Myeloma
    • Bone Marrow samples collection
    • Strasbourg, France
      Institut de cancérologie Strasbourg Europe
    Mar 15, 2023

    Multiple Myeloma, Relapse, Refractory Trial in Chapel Hill, Winston-Salem, Columbus (Isatuximab, Pomalidomide, Dexamethasone)

    Not yet recruiting
    • Multiple Myeloma
    • +4 more
    • Chapel Hill, North Carolina
    • +2 more
    Jun 9, 2023

    Relapsed/Refractory Multiple Myeloma Trial in United States (KITE-585, Cyclophosphamide, Fludarabine)

    Terminated
    Has Results
    • Relapsed/Refractory Multiple Myeloma
    • KITE-585
    • +2 more
    • Los Angeles, California
    • +8 more
    Oct 4, 2022

    Multiple Myeloma Trial in New York (drug, biological, procedure)

    Active, not recruiting
    • Multiple Myeloma
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jan 3, 2023

    Multiple Myeloma Prognostic Indices

    Recruiting
    • Multiple Myeloma
    • Hematologic Diseases
    • blood viscosity , albumin / fibrinogen ratio and red cell distribution
    • Assiut, Egypt
      Assiut University hospital
    Oct 17, 2023